KFU. Card publication. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo- controlled, phase 2 trial

- RUS
- 中文
- ES

ANTI-INTERLEUKIN-21 ANTIBODY AND LIRAGLUTIDE FOR THE PRESERVATION OF β-CELL FUNCTION IN ADULTS WITH RECENT-ONSET TYPE 1 DIABETES: A RANDOMISED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PHASE 2 TRIAL

Form of presentation

Articles in Russian journals and collections

Year of publication

2021

��

��

Authors, employees of KFU

Gaysina Leylya Rafaelevna, author

Other authors

Bain Stephen , author

Bode Bruce , author

Clausen Jesper Ole , author

Coppieters Ken , author

Gumprecht Janusz , author

Hansen Troels Krarup , author

von Herrath Matthias , author

Bibliographic description in the original language

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo- controlled, phase 2 trial // Lancet Diabetes Endrocrinol 2021; 9: 212–224

Keywords

diabetes 1 type

The name of the journal

The Lancet

On-line resource for training course

http://dspace.kpfu.ru/xmlui/bitstream/handle/net/163520/F_von__errath_2021_TLDE_4150_Lira___anti_IL_21_prim_masnucript_epub__1_.pdf?sequence=1&isAllowed=y

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=251429&p_lang=2

Resource files

File name	Size (MB)	Format
F_von__errath_2021_TLDE_4150_Lira___anti_IL_21_prim_masnucript_epub__1_.pdf	0,51	pdf	show / download

Full metadata record

Field DC	Value	Language
dc.contributor.author	Gaysina Leylya Rafaelevna	ru_RU
dc.contributor.author	Bain Stephen	ru_RU
dc.contributor.author	Bode Bruce	ru_RU
dc.contributor.author	Clausen Jesper Ole	ru_RU
dc.contributor.author	Coppieters Ken	ru_RU
dc.contributor.author	Gumprecht Janusz	ru_RU
dc.contributor.author	Hansen Troels Krarup	ru_RU
dc.contributor.author	von Herrath Matthias	ru_RU
dc.date.accessioned	2021-01-01T00:00:00Z	ru_RU
dc.date.available	2021-01-01T00:00:00Z	ru_RU
dc.date.issued	2021	ru_RU
dc.identifier.citation	Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo- controlled, phase 2 trial // Lancet Diabetes Endrocrinol 2021; 9: 212–224	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=251429&p_lang=2	ru_RU
dc.description.abstract	The Lancet	ru_RU
dc.language.iso	ru	ru_RU
dc.subject		ru_RU
dc.title	Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo- controlled, phase 2 trial	ru_RU
dc.type	Articles in Russian journals and collections	ru_RU